Endothelin-1 and Nitric Oxide Concentrations and Their Response to Exercise in Patients with Slow Coronary Flow

Circulation Journal

Volumn 67, Issue 12, 2003, Pages 1022-1028

  Çamsari, Ahmet ^a,b   Pekdemir, Hasan ^a   Çiçek, Dilek ^a   Polat, Gürbüz ^a   Akkuş, M Necdet ^a   Döven, Oben ^a   Cin, V Gökhan ^a   Katircibaşi, Tuna ^a   Parmaksiz, Tuncay ^a  

^a MERSIN UNIVERSITY   (Turkey)

^b MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Endothelin 1; Nitric oxide; Slow coronary flow

Indexed keywords

ENDOTHELIN 1; NITRIC OXIDE;

ADULT; ANGIOCARDIOGRAPHY; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORRELATION ANALYSIS; EXERCISE; EXERCISE TEST; FEMALE; HEART RATE; HUMAN; HUMAN TISSUE; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN FUNCTION; SLOW CORONARY FLOW;

ANGINA PECTORIS; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CORONARY DISEASE; ENDOTHELIN-1; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 0344738771     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.1022     Document Type: Article

References (42)

1. Kemp HG, Kronmal RA, Vlietstra RE, Frye RL. Seven year survival of patients with normal or near normal coronary arteriograms: A CASS Registry study. J Am Coll Cardiol 1986; 7: 479-483.
2. Kemp HG Jr. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol 1973; 32: 375-376.
3. Voelker W, Euchaner U, Dittmann H, Karsch KR. Long-term clinical course of patients with angina and angiographically normal coronary arteries. Clin Cardiol 1991; 1: 4307-4311.
4. Goel PK, Gupta SK, Agarwal A, Kapoor A. Slow coronary flow: A distinct angiographic subgroup in syndrome X. Angiology 2001; 52: 507-514.
5. Lierde JV, Vrolix M, Sionis D, De Geest H, Piessens J. Lack of evidence for small vessel disease in a patient with 'slow dye progression' in the coronary arteries. Cathet Cardiovasc Diagn 1991; 23: 117-120.
6. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries: A new angiographic finding. Am Heart J 1972; 84: 66-71.
7. Sezgin AT, Sigirci A, Barutcu I. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis 2003; 14: 155-161.
8. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986; 74: 964-972.
9. Mangieri E, Macchiarelli G, Ciavolella M, Barilla F, Avella A, Martinotti A, et al. Slow coronary flow: Clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 1996; 37: 375-381.
10. Kurtoglu N, Akcay A, Dindar I. Usefulness of oral dipyridamole therapy for angiographic slow coronary artery flow. Am J Cardiol 2001; 87(Suppl 8A): 777-779.
11. Luscher TF, Tanner FC. Endothelial regulation of vascular tone and growth (Review). Am J Hypertens 1993; 6: 283-293.
12. Tamirisa P, Frishman WH, Kumar A. Endothelin and endothelin antagonism: Roles in cardiovascular health and disease. Am Heart J 1995; 130: 601-610.
13. Galatius S, Wroblewski H, Emmeluth C. Plasma ET-1 in chronic heart failure: A predictor of cardiac death (abstract)? Circulation 1994; 90:I-379.
14. Kaski JC, Elliot PM, Salomone O, Dickinson K, Gordon D, Hann C, et al. Concentration of circulating plasma endothelin in patients with angina and normal coronary angiograms. Br Heart J 1995; 74: 620-624.
15. Kaski JC, Cox ID, Crook JR, Salomone OA, Fredericks S, Hann C, et al. Differential plasma endothelin concentrations in subgroups of patients with angina and angiographically normal coronary arteries: Coronary artery Disease Research Group. Am Heart J 1998; 136: 412-417.
16. Lubov T, Marmor A, Gorenberg M. Endothelin release: A marker for the severity of exercise-induced ischemia. Int J Cardiol 2001; 79: 19-24.
17. Lanza GA, Luscher TF, Pasceri V, Shaw SG, Buffon A, Montenero AS, et al. Effects of atrial pacing on arterial and coronary sinus endothelin-1 concentrations in syndrome-X. Am J Cardiol 1999; 84: 1187-1191.
18. Chauhan A, Mullins PA, Taylor M, Petch MC, Schofield PM. Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms. Eur Heart J 1997; 18: 60-68.
19. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, et al. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-888.
20. Fletcher GF, Balady G, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards: A statement for health professionals from the American Heart Association. Circulation 1990; 82: 2286-2321 (Revised Circulation 1995; 91: 580-632).
21. Fletcher GF, Balady G, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards: A statement for health professionals from the American Heart Association. Circulation 1990; 82: 2286-2321 (Revised Circulation 1995; 91: 580-632).
22. Shue P, Froelicher V. Extra: An expert system for exercise reporting. J Noninvasive Testing 1998; 2: 21-27.
23. James TN. Small arteries of the heart. Circulation 1977; 56: 2-14.
24. Ratcliffe HL, Redfield E. Atherosclerotic stenosis of the extramural and intramural coronary arteries of man: Related lesions. Virchows Arch A Pathol Pathol Anat 1972; 357: 1-10.
25. Chilian WM, Dellsperger KC, Layne SM, Eastham CL, Armstrong MA, Marcus ML, et al. Effects of atherosclerosis on the coronary microcirculation. Am J Physiol 1990; 258: H529-H539.
26. Zeiher AM, Schachlinger V, Hohnloser SH, Saurbier B, Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans: Elevated high-density lipoprotein concentrations ameliorate abmormal vasoconstriction in early atherosclerosis. Circulation 1994; 89: 2525-2532.
27. Nakatani S, Yamagishi M, Tamai J, Goto Y, Umeno T, Kawaguchi A, et al. Assessment of coronary artery distensibility by intravascular ultrasound application of simultaneous measurements of luminal area and pressure. Circulation 1995; 91: 2904-2910.
28. Mintz GS, Painter JA, Pichard AD, Kent KM, Satler LF, Popma JJ, et al. Atherosclerosis in angiographically 'normal' coronary artery reference segments: An intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995; 25: 1479-1485.
29. Tuzcu EM, Kapadia SR, Tutar E, Ziada KM, Hobbs RE, McCarthy PM, et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: Evidence from intravascular ultrasound. Circulation 2001; 103: 2705-2710.
30. Wiedermann JG, Schwartz A, Apfelbaum M. Anatomic and physiologic heterogeneity in patients with syndrome X: An intravascular ultrasound study. J Am Coll Cardiol 1995; 25: 1310-1317.
31. Highsmith RF, Blackburn K, Schmidt DJ. Endothelin and calcium dynamics in vascular smooth muscle. Annu Rev Physiol 1992; 54: 257-277.
32. Egashira K, Katsuda Y, Mohri M, Kuga T, Tagawa T, Kubota T, et al. Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans. Circ Res 1996; 79: 331-335.
33. Lerman A, Holmes DR Jr, Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 1995; 92: 2426-2431.
34. Lanza GA, Luscher TF, Pasceri V, Shaw SG, Buffon A, Montenero AS, et al. Effects of atrial pacing on arterial and coronary sinus endothelin-1 concentrations in syndrome X. Am J Cardiol 1999; 84: 1187-1191.
35. Embrey RP, Brooks LA, Dellsperger KC. Mechanism of coronary microvascular responses to metabolic stimulation. Cardiovasc Res 1997; 35: 148-157.
36. Tousoulis D, Davies GJ, Crake T, Toutouzas PC. Vasomotion and nitric oxide bioactivity in diseased coronary arteries. Heart 2002; 87: 320-321.
37. Buus NH, Bottcher M, Bottker HE, Sorensen KE, Nielsen TT, Mulvany MJ. Reduced vasodilator capacity in syndrome X related to structure and function of resistance arteries. Am J Cardiol 1999; 83: 149-154.
38. Feigl EO. Adrenergic control of transmural coronary blood flow. Basic Res Cardiol 1990; 85(Suppl I): 167-175.
39. Zehier AM, Drexler H, Wollschlaeger H, Saurbier B, Just H. Coronary vasomotion in response to sympathetic stimulation in humans: Importance of the functional integrity of the endothelium. J Am Coll Cardiol 1989; 14: 1181-1190.
40. Cordero DL, Cagin NA, Natelson BH. Neurocardiology update: Role of the nervous system in coronary vasomotion. Cardiovasc Res 1995; 29: 319-328.
41. Aronson D, Mittleman MA, Burger AJ. Role of endothelin in modulation of heart rate variability in patients with decompensated heart failure. Pacing Clin Electrophysiol 2001; 24: 1607-1615.
42. Papadakis MC, Manginas A, Cotileas P, Demopoulos V, Voudris V, Pavlides G, et al. Documentation of slow coronary flow by the TIMI frame count in patients with coronary ectasia. Am J Cardiol 2001; 88: 1030-1032.